Sutter Health taps Ferrum Health for AI-based 'safety net' for lung cancer scans

Healthcare IT News | February 18, 2020

Northern California healthcare system Sutter Health announced today that has begun a pilot with startup Ferrum Health, to use AI to monitor the work of radiologists and catch preventable medical errors in patients with lung cancer. Ferrum is a new startup founded by Pelu Tran, who previously founded and led Google Glass company Augmedix. It’s an AI company, but rather than building its business model on selling particular algorithms, it’s focused on deploying existing algorithms in a new way: as a background-monitoring “safety net” that only requires active attention from radiologists when it detects a discrepancy with their diagnoses. Coming out of my previous company and the strength that we had working with healthcare systems like Sutter we really realized that AI could be used in a few different ways, but that physicians, given all the pressures that they were under, were going to really struggle to carve out time in their workflow, in their day-to-day, to deploy solutions that are really focused on improving quality," said Tran.

Spotlight

New data from an ongoing post-marketing study in nearly 45,000 people with non-valvular atrial fibrillation (NVAF) confirm the safety profile of XARELTO® (rivaroxaban) was generally consistent with the findings observed in ROCKET AF, the Phase 3 study that supported the approval of the medicine for prevention of stroke in patients with NVAF.

Spotlight

New data from an ongoing post-marketing study in nearly 45,000 people with non-valvular atrial fibrillation (NVAF) confirm the safety profile of XARELTO® (rivaroxaban) was generally consistent with the findings observed in ROCKET AF, the Phase 3 study that supported the approval of the medicine for prevention of stroke in patients with NVAF.

Related News

HEALTH TECHNOLOGY

Innovaccer Announces Connected Digital Health Solution for Biopharma and Medtech

Innovaccer and Health Cloud | July 07, 2022

Innovaccer, the Health Cloud company, announced its Connected Digital Health solution, a new way for life sciences companies to rapidly deliver next-generation digital apps that surround therapeutics and devices with highly engaging patient experiences, improve clinical outcomes, and generate valuable real world evidence. With Innovaccer’s Connected Digital Health solution, biopharma and medtech companies will be able to speed time-to-market of patient-centric apps that connect patients to their care teams and deliver real-time health insights into their physicians’ workflows. Providers and patients alike will be able to act on these insights to improve care management and adherence, factors proven to enhance the quality of care. In addition, Innovaccer’s Connected Digital Health solution will enable patient- and population-level RWE to be generated and delivered to biopharma and medtech brands for indicating their real-world use, benefits, and potential target populations; identifying label expansion opportunities, supporting clinical trial designs and observational studies—ultimately providing crucial insights for further drug and device innovation. “Creating digital health apps with a unified brand-provider-patient workflow is the next great vista for pharma brands and we can help them cross it. In an increasingly crowded market, launching another ‘me-too’ app isn’t enough for brands to succeed. Pharma brands must surround their products with ‘sticky’ experiences that exceed patients’ expectations when compared to the disconnected, point-solution apps patients typically ignore. With Innovaccer, pharma will be able to put an end to health app abandonment with connected health applications that patients really want to use.” Kanav Hasija, chief customer officer and cofounder of Innovaccer As a proven leader in value-based care and population health management, Innovaccer is ideally suited to help biopharma and medtech companies unlock the full value of their innovations by integrating them within care workflows, in partnership with providers and health plans. To date, Innovaccer has unified patient records for more than 39 million people across more than 1,600 care settings, including EHRs, labs, pharmacy, telehealth, remote care, devices, and more. “Digital health app abandonment is a real problem for the industry,” says Abhinav Shashank, CEO and cofounder at Innovaccer. “There are over 350,000 digital health apps today, yet 83% were installed fewer than 5,000 times. They’re not compelling to patients because they work in isolation from the patient’s EHR, care team, and in many cases, the therapeutic brands themselves. We will change that by wrapping a brand-provider-patient workflow around the therapeutic or device that sends clinical insights into provider workflows, creating an end-to-end disease management system. Insights from digital apps will be actionable within the care workflow to everyone: the patient, the provider, and the pharma brand. Innovaccer’s Connected Digital Health solution represents the next generation of digital disease management.” About Innovaccer Innovaccer Inc., the Health Cloud company, is dedicated to accelerating innovation in healthcare. The Innovaccer® Health Cloud unifies patient data across systems and care settings, and empowers healthcare organizations to develop scalable, modern applications that improve clinical, financial, and operational outcomes. Innovaccer’s solutions have been deployed across more than 1,600 care settings in the U.S., enabling more than 96,000 providers to transform care delivery and work collaboratively with payers and life sciences companies. Innovaccer has helped its customers unify health records for more than 39 million people and generate over $1B in cumulative cost savings. Innovaccer is the #1 rated Data and Analytics Platform by KLAS, and the #1 rated population health technology platform by Black Book.

Read More

FUTURE OF HEALTHCARE

Jvion AI and SDoH Solutions Acquired by Lightbeam

Lightbeam Health Solutions, Inc., | June 01, 2022

Lightbeam Health Solutions Inc., an organization at the forefront of population health management, announced that it has signed an asset purchase agreement to acquire Jvion, Inc., and the firm’s cutting-edge, AI-enabled social determinants of health (SDoH) solutions. “Together, Lightbeam and Jvion’s technologies will bring critical, proactive, and scalable insights to populations across all types of value-based care models. The Jvion team believes strongly in the purpose and promise of our integrated offerings, and I am excited for the Jvion team to begin this next chapter with Lightbeam.” Tom Zajac, Executive Chairman of Jvion The acquisition is a strategic move for Lightbeam considering Jvion’s client base will be able to access CareSignal and other advanced range of Deviceless Remote Patient Monitoring® (RPM) programs. They are known to improve clinical processes and decrease utilization across patient populations. The acquisition is aimed at benefiting Jvion clients by boosting the value of its existing solution. The agreement will cement the position of the combined partnership as a front runner in population health management through a well-designed product offering that includes the following Data Aggregation and Analytics that seamlessly integrates clinical workflows, organizes risk stratification, and coverts insights into results Predictive Models and AI that can predict patient risk and jumpstart clinical intervention Deviceless Remote Patient Monitoring improves staffing efficiency by delivering patient screening and care management to patients regardless of where they are in the care journey For current Jvion customers and partners, your success is our success. The breadth and timeliness of the combined technology and services will extend fully, and as a top priority, to our clients and partners. Pat Cline, CEO of Lightbeam

Read More

HEALTH TECHNOLOGY

Innovaccer Expands Global Footprint, Enters U.K. Market to Deliver Digital Transformation in Healthcare

Innovaccer Inc., | June 24, 2022

The Health Cloud firm, Innovaccer Inc., declared that as part of its growth into the UK healthcare industry, it will build an office in London. To support the legislative reforms of the NHS Health and Care Act 2022, Innovaccer offers data-driven technological solutions that can speed up innovation and digital transformation. The company's long-term expansion strategy and dedication to improving healthcare access, affordability, and quality around the world are both supported by the opening of the London office. The NHS recommended in 2019 that its design be changed in order to "improve coordination of services through the construction of Integrated Care Systems." The Health and Care Act of 2021 offered a framework to make it easier for the NHS, local governments, and other stakeholders to work together and promote the pandemic's recovery. The bill was enlarged by the Health and Care Act 2022, which included a wide variety of policy changes targeted at strengthening health and care services through improved integration of health and care and addressing growing health inequities. “The UK healthcare landscape is one of the best in the world. NHS England’s long-term plan clearly sets the direction for widespread digital services that can support and empower people to stay healthy and independent for longer. But they also acknowledge the challenge of identifying a technology provider that’s experienced with healthcare data. With Innovaccer’s data and analytics platform backed by a unified patient record, we can move towards addressing inequalities in health and population health, as well as wellbeing and the quality of services as part of the triple aim for NHS”. John Gurnett, General Manager, UK and Europe, Innovaccer More than 1,600 care settings have used Innovaccer's solutions. Over 39 million patients' records have been merged, helping over 96,000 caregivers work more cooperatively and saving more than £800 million as a result. Leading healthcare organizations have seen results like a 6.6 percent decrease in emergency room use, a 6.6 percent decrease in readmissions, and a 13 percent increase in referral success rate. “This is a milestone for the company in achieving our vision and for healthcare. By integrating data from multiple domains within the NHS and from local agencies, Innovaccer can help bridge the collaboration gap and provide analytics and actionable insights to meet the goals as set out by the Health and Care Act 2022—to improve the quality of care and reduce costs. Innovaccer’s capabilities in care coordination and population health will accelerate NHS’s vision of enabling people to live healthier and more independent lives through high-quality, seamless care”. Abhinav Shashank, co-founder and CEO of Innovac

Read More